SCHEMBL2444548

SCHEMBL2444548

CN1CCCc2cc(C=NO)cc(Cl)c21

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.41
MEN1 O00255 2/20 0.41
MAPT P10636 2/20 0.41
HPGD P15428 2/20 0.41
KMT2A Q03164 2/20 0.41
GAA P10253 1/20 0.41
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
PKM P14618 1/20 0.35
CYP2C19 P33261 1/20 0.35
NPC1 O15118 1/20 0.35
THRB P10828 1/20 0.35
RAB9A P51151 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
HTT P42858 3/20 0.34
NOTUM Q6P988 1/20 0.34
HSD17B10 Q99714 1/20 0.33
LMNA P02545 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2444546 1.00 ALDH1A1 (0.41) ALDH1A1MEN1MAPTHPGDKMT2A
SCHEMBL10063324 0.77 KMT2A (0.46) ALDH1A1MEN1MAPTHPGDKMT2A
SCHEMBL14740917 0.75 ALDH1A1 (0.68) ALDH1A1MEN1MAPTHPGDKMT2A
SCHEMBL14740918 0.75 ALDH1A1 (0.68) ALDH1A1MEN1MAPTHPGDKMT2A
SCHEMBL16440968 0.75 ALDH1A1 (0.68) ALDH1A1MEN1MAPTHPGDKMT2A
SCHEMBL12330396 0.73 NOTUM (0.39) ALDH1A1MEN1MAPTHPGDKMT2A
SCHEMBL2450374 0.73 ALDH1A1 (0.36) ALDH1A1MEN1MAPTHPGDKMT2A
SCHEMBL2450372 0.73 ALDH1A1 (0.36) ALDH1A1MEN1MAPTHPGDKMT2A
SCHEMBL22004779 0.72 NOTUM (0.38) ALDH1A1MEN1MAPTHPGDKMT2A
SCHEMBL12401783 0.70 NOTUM (0.36) ALDH1A1MEN1MAPTHPGDKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2366704-B1 Inhibitors of serine proteases VERTEX PHARMA (US) 2013-10-23 EP disclosed
EP-2631238-A1 Spirocyclic inhibitors of serine proteases for the treatment of hcv infections VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-08-28 EP disclosed
EP-1917269-B1 INHIBITORS OF SERINE PROTEASES VERTEX PHARMA (US) 2011-10-26 EP disclosed
EP-2366704-A1 Inhibitors of serine proteases VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-09-21 EP disclosed
EP-2364984-A1 Inhibitors of serine proteases VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-09-14 EP disclosed